retatrutide triple agonist glp-1 gip glucagon receptor The TRIUMPH-1 Phase 3 results just dropped on retatrutide. Here is what the numbers actually say. is a agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro retatrutide triple agonist glp-1 gip

In liver disease, semaglutide received FDA accelerated approval in August 2025 for metabolic dysfunction-associated steatohepatitis in adults with moderate-to-advanced fibrosis

Dual agonism with GLP-1 and amylin As WL with GLP-1 RA and amylin analogues results both from distinct and overlapping pathways, a combination of these entero-pancreatic hormones may induce a synergistic WL effect [84]

See: Zepbound for Sleep Apnea)

Back Schaffer, R (27 June 2021) 'Discovering gut hormones: A conversation with Jens J

More than 5 days past your scheduled day: Skip the missed dose entirely

Multivariate Cox regression analysis was performed using the high-dimensional propensity score (HDPS) to obtain adjusted HR estimates